Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
13 February 2025 - 10:40AM
Edgar (US Regulatory)
Exhibit A
JOINT FILING AGREEMENT
The undersigned agree that
this Schedule 13G Amendment No. 1 dated February 12, 2025 relating to the Common Stock, par value $0.001 per share, of Marinus Pharmaceuticals,
Inc. shall be filed on behalf of the undersigned.
|
SOFINNOVA INVESTMENTS, INC.
By: /s/ James Healy |
|
Name: James Healy |
|
Title: Director |
|
SOFINNOVA BIOEQUITIES GP LLC
By: /s/ Eric Delbridge |
|
Name: Eric Delbridge |
|
Title: Managing Member |
|
JAMES HEALY
By: /s/ James Healy |
|
ERIC DELBRIDGE
By: /s/ Eric Delbridge |
Exhibit B
CONTROL PERSON IDENTIFICATION
Sofinnova Investments, Inc. and Sofinnova BioEquities GP LLC are
the relevant entities for which James Healy and Eric Delbridge, respectively, may be considered control persons.
Marinus Pharmaceuticals (NASDAQ:MRNS)
Historical Stock Chart
From Jan 2025 to Feb 2025
Marinus Pharmaceuticals (NASDAQ:MRNS)
Historical Stock Chart
From Feb 2024 to Feb 2025